Cell No. : Cell Name
RCB1148 : TGBC11TKB
update : 2021/01/08
|
| Comment | Japanese gastric cancer, lymph node metastated. Application consideration |
| Comment from the depositor | |
| Terms and conditions | There is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC. |
| Remarks | |
| Order Form |
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, Category I and II, depending on the sort of user institutions and the purposes of use.Please use an appropriate MTA(to see).In case of Restriction "a" or "f", please contact RIKEN BRC(cellbank.brc@riken.jp) regarding any kind of for-profit use.
|
|
|
Basic information
|
Depositor |
Ohno, T. & Todoroki, T.
|
| Originator |
Kim, B. & Ohno, Tadao
|
| Year of deposit |
1995
|
| Another name |
NaTo
|
| Animal |
human
< Mammals
|
| Genus |
Homo
|
| Species |
sapiens
|
| Race |
Japanese
|
| Gender |
Female
|
| Age at sampling |
72 years
|
| Tissue |
stomach, lymph node meta
|
| Classification |
cancer
|
| Year of origin |
1995
|
|
Lifespan |
infinite
|
| Morphology |
epithelial-like
|
|
| |
deposit info |
lot info |
|
Medium |
Medium List |
|
Culture type |
|
Adherent cells
|
| Medium and additives |
|
DMEM (low glucose) + 5% FBS
|
| Antibiotics |
|
Free
|
|
Passage method |
|
pipetting
|
Culture information
|
Passage ratio |
|
1 : 8 split
|
| SC frequency |
|
Subculture : once/week, Medium Renewal : 2 times/week
|
| Temperature |
|
37
℃
|
| CO2 concentration |
|
5
%
|
| Freeze medium |
|
Medium + 10% DMSO
|
| Freezing method |
|
Slow freezing
|
| Mycoplasma |
|
(-)
|
| STR(human) |
|
OK
|
| Virus (HIV) |
|
(-)
|
| Isozyme |
|
LD, NP
|
| Chromosome mode |
|
42-95(50) : 42(5),43(5),44(6),45(11),46(6),47(6)/
|
| Reference information |
Reference |
0
|
| User's Publication |
7
|
| User's Publication |
|
11511
Behan FM, Iorio F, Picco G, Gonçalves E, Beaver CM, Migliardi G, Santos R, Rao Y, Sassi F, Pinnelli M, Ansari R, Harper S, Jackson DA, McRae R, Pooley R, Wilkinson P, van der Meer D, Dow D, Buser-Doepner C, Bertotti A, Trusolino L, Stronach EA, Saez-Rodriguez J, Yusa K, Garnett MJ.
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens.
Nature
2019
PubMed ID: 30971826
|
|
3734
Cirmi S, Maugeri A, Ferlazzo N, Gangemi S, Calapai G, Schumacher U, Navarra M.
Anticancer Potential of Citrus Juices and Their Extracts: A Systematic Review of Both Preclinical and Clinical Studies.
Front Pharmacol
2017
8:420
PubMed ID: 28713272
|
|
9928
Diaz-Lagares A, Crujeiras AB, Lopez-Serra P, Soler M, Setien F, Goyal A, Sandoval J, Hashimoto Y, Martinez-Cardús A, Gomez A, Heyn H, Moutinho C, Espada J, Vidal A, Paúles M, Galán M, Sala N, Akiyama Y, Martínez-Iniesta M, Farré L, Villanueva A, Gross M, Diederichs S, Guil S, Esteller M.
Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer.
Proc. Natl. Acad. Sci. U.S.A.
2016
113:E7535-E7544
PubMed ID: 27821766
|
|
3733
Nishikawaji T, Akiyama Y, Shimada S, Kojima K, Kawano T, Eishi Y, Yuasa Y, Tanaka S.
Oncogenic roles of the SETDB2 histone methyltransferase in gastric cancer.
Oncotarget
2016
7(41):67251-67265
PubMed ID: 27572307
|
|
3719
van Haaften G et al
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer.
Nat Genet
2009
41(5):521-3
PubMed ID: 19330029
|
|
6410
Danjoh I, Sone H, Noda N, Iimura E, Nagayoshi M, Saijo K, Hiroyama T, Nakamura Y.
Is parainfluenza virus a threatening virus for human cancer cell lines?
Hum Cell
2009
22(3):81-4
PubMed ID: 19624309
|
|
6139
Jin SH, Akiyama Y, Fukamachi H, Yanagihara K, Akashi T, Yuasa Y.
IQGAP2 inactivation through aberrant promoter methylation and promotion of invasion in gastric cancer cells.
Int J Cancer
2008
122(5):1040-6
PubMed ID: 17957782
|
Back
Top
CELL BANK Website